Acción VPA AVEO PHARMACEUTICALS, INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas AVEO Pharmaceuticals, Inc. Börse Stuttgart

Acciones

VPA

US0535881090

Diferido Börse Stuttgart
Otros sitios de cotización
 16:33:53 05/10/2021 		Varia. Cinco días. Varia. 1 de enero.
5,28 EUR -0,19 % Gráfico intradía de AVEO Pharmaceuticals, Inc. -10,02 % +20,93 %
13/06 LG Chem Company y AVEO Oncology anuncian que el primer compuesto anticanceroso patentado de LG Chem entra en el estudio clínico de fase 1 y se inicia la dosificación en EE.UU. CI
25/03 AVEO Pharmaceuticals, Inc. anuncia cambios ejecutivos CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!
Inscripción 100% Gratuita
LG Chem Company and AVEO Oncology Announce LG Chem's First Proprietary Anti-Cancer Compound Enters Phase 1 Clinical Study, Dosing Initiated in the U.S
AVEO Pharmaceuticals, Inc. Announces Executive Changes
Aveo Oncology Announces Publication of Long-Term Survival in Patients with Relapsed/Refractory Advanced Renal Cell Carcinoma Treated with Tivozanib: Analysis of the Phase Iii Tivo-3 Trial in the Oncologist
AVEO Oncology Enrolls First Patient in Pivotal FIERCE-HN Clinical Trial to Evaluate Ficlatuzumab in Combination with ERBITUX® in Patients with HPV-negative Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
AVEO Oncology Announces Completion of Enrollment in Pivotal Phase 3 TiNivo-2 Study of FOTIVDA(R) in Combination with OPDIVO(R) in Advanced Renal Cell Carcinoma
South Korean Stocks Climb on Demand Recovery Hopes from China; LG Chem Stocks Add 1%
AVEO Completes Acquisition by LG Chem
LG Chem Acquires US Biopharma Firm AVEO Pharmaceuticals
AVEO PHARMACEUTICALS, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)
LG Chem Completes Acquisition of AVEO Oncology
AVEO Pharmaceuticals, Inc. Announces Management Changes
AVEO Oncology Appoints Martin Birkhofer as Its Chief Medical Officer
AVEO Pharmaceuticals, Inc.(NasdaqCM:AVEO) dropped from NASDAQ Composite Index
AVEO Pharmaceuticals, Inc.(NasdaqCM:AVEO) dropped from S&P Global BMI Index
AVEO Pharmaceuticals, Inc.(NasdaqCM:AVEO) dropped from S&P TMI Index
LG Chem, Ltd. completed the acquisition of AVEO Pharmaceuticals, Inc. from a group of shareholders.
AVEO Pharmaceuticals Receives CFIUS Clearance for LG Chem Merger
AVEO Pharmaceuticals : Merger Agreement - Form 8-K
AVEO PHARMACEUTICALS, INC. : Other Events (form 8-K)
AVEO Pharmaceuticals Stockholders Approve LG Chem Merger
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción AVEO
  4. Acción VPA
  5. Noticias AVEO Pharmaceuticals, Inc.
  6. Otros idiomas